(Q44297745)

1 December 2017

title

Effectiveness of chromium in atypical depression: a placebo-controlled trial (English)

1 reference

1 December 2017

1 reference

Jonathan R T Davidson

1

1 reference

1 December 2017

Kurian Abraham

2

1 reference

1 December 2017

Kathryn M Connor

3

1 reference

1 December 2017

Malcolm N McLeod

4

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

1 December 2017

published in

Biological Psychiatry

1 reference

1 December 2017

volume

53

1 reference

1 December 2017

issue

3

1 reference

1 December 2017

page(s)

261-264

1 reference

Chromium, Glucose Intolerance and Diabetes

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901500-7

Effects of supplemental chromium on patients with symptoms of reactive hypoglycemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901500-7

Chromium treatment decreases the sensitivity of 5-HT2A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901500-7

Tolerability of fluoxetine in posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901500-7

Adverse-effect profile of kava

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901500-7

An efficacy study of isocarboxazid and placebo in depression, and its relationship to depressive nosology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901500-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901500-7

Classification of depression by grade of membership: a confirmation study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901500-7

Chromium oligopeptide activates insulin receptor tyrosine kinase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901500-7

The effect of treatment on the melancholias (depressions).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901500-7

The relationship between central serotonergic activity and insulin sensitivity in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901500-7

Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901500-7

Enhancing central and peripheral insulin activity as a strategy for the treatment of endogenous depression--an adjuvant role for chromium picolinate?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901500-7

Chromium potentiation of antidepressant pharmacotherapy for dysthymic disorder in 5 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901500-7

Chromium treatment of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901500-7

Fluoxetine versus phenelzine in atypical depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901500-7

Classification of Depressed Patients: A Cluster Analysis Derived Grouping

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901500-7

Amitriptyline, weight gain and carbohydrate craving: a side effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901500-7

Partial validation of the atypical features subtype of major depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901500-7

A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901500-7

10.1016/S0006-3223(02)01500-7

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference